Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization

Intensive Care Medicine

Volumn 41, Issue 6, 2015, Pages 1077-1088

  Ferreira, David ^a   Grenouillet, Frederic ^a,b   Blasco, Gilles ^a   Samain, Emmanuel ^a,c   Hénon, Thierry ^a   Dussaucy, Alain ^a   Millon, Laurence ^a,b   Mercier, Mariette ^a,b   Pili Floury, Sebastien ^a,c  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c Bâtiment Socrate   (France)

Author keywords

Antifungal drug; Candida colonization; Drug utilization

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CRITICALLY ILL PATIENT; FEMALE; FUNGAL COLONIZATION; HUMAN; INTENSIVE CARE UNIT; KLUYVEROMYCES MARXIANUS; MAJOR CLINICAL STUDY; MALE; MEYEROZYMA GUILLIERMONDII; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; OBSERVATIONAL STUDY; PICHIA NORVEGENSIS; RETROSPECTIVE STUDY; ADULT; AGED; CANDIDIASIS; CRITICAL CARE OUTCOME; CRITICAL ILLNESS; CROSS INFECTION; DRUG UTILIZATION; INCIDENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PREVALENCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CRITICAL CARE OUTCOMES; CRITICAL ILLNESS; CROSS INFECTION; DRUG UTILIZATION; FEMALE; FLUCONAZOLE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84931957627     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3791-4     Document Type: Article

References (39)

1. Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3:685–702
2. Bassetti M, Merelli M, Righi E et al (2013) Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51:4167–4172. doi:10.1128/jcm.01998-13
3. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163. doi:10.1128/cmr.00029-06
4. Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK (2011) Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 49:3300–3308. doi:10.1128/jcm.00179-11
5. Puig-Asensio M, Peman J, Zaragoza R, Garnacho-Montero J, Martin-Mazuelos E, Cuenca-Estrella M, Almirante B (2014) Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med 42:423–432. doi:10.1097/ccm.0000000000000221
6. Pappas PG, Kauffman CA, Andes D et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535. doi:10.1086/596757
7. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN (1994) Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 32:975–980
8. Leon C, Ostrosky-Zeichner L, Schuster M (2014) What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40:808–819. doi:10.1007/s00134-014-3281-0
9. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758
10. Eggimann P, Pittet D (2014) Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med 40:1429–1448. doi:10.1007/s00134-014-3355-z
11. Bassetti M, Marchetti M, Chakrabarti A et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–2106. doi:10.1007/s00134-013-3109-3
12. Cornely OA, Bassetti M, Calandra T et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19–37. doi:10.1111/1469-0691.12039
13. Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A (2004) Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443–2449
14. Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G (2014) Invasive fungal infections in the ICU: how to approach, how to treat. Molecules 19:1085–1119. doi:10.3390/molecules19011085
15. Eggimann P, Francioli P, Bille J et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072
16. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717. doi:10.1007/s00134-002-1540-y
17. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA (2001) Double-blind placebo-controlled trial of fluconazole to prevent Candidal infections in critically ill surgical patients. Ann Surg 233:542–548
18. Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH (2005) Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 33:1928–1935
19. Schuster MG, Edwards JE Jr, Sobel JD et al (2008) Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 149:83–90
20. Albert M, Williamson D, Muscedere J, Lauzier F, Rotstein C, Kanji S, Jiang X, Hall M, Heyland D (2014) Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med 40:1313–1322. doi:10.1007/s00134-014-3352-2
21. De Pascale G, Antonelli M (2014) Candida colonization of respiratory tract: to treat or not to treat, will we ever get an answer? Intensive Care Med 40:1381–1384. doi:10.1007/s00134-014-3364-y
22. Ostrosky-Zeichner L, Shoham S, Vazquez J et al (2014) MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis 58:1219–1226. doi:10.1093/cid/ciu074
23. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55:532–538. doi:10.1128/aac.01128-10
24. Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF (2012) Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med 40:813–822. doi:10.1097/CCM.0b013e318236f297
25. Gleason TG, May AK, Caparelli D, Farr BM, Sawyer RG (1997) Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units. Arch Surg 132:1197–1201 (discussion 1202)
26. Rocco TR, Reinert SE, Simms HH (2000) Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch Surg 135:160–165
27. Dimopoulos G, Velegraki A, Falagas ME (2009) A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrob Agents Chemother 53:1242–1244. doi:10.1128/aac.01368-08
28. Playford EG, Nimmo GR, Tilse M, Sorrell TC (2010) Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999–2008. J Hosp Infect 76:46–51. doi:10.1016/j.jhin.2010.01.022
29. WHO collaborating centre for drug statistics methodology (2014) Guidelines for ATC classification and DDD assignment, 2015. Oslo. http://www.whocc.no/atc_ddd_publications/guidelines/
30. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R (1991) Increase in Candidakrusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274–1277. doi:10.1056/nejm199110313251803
31. Fournier P, Schwebel C, Maubon D et al (2011) Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. J Antimicrob Chemother 66:2880–2886. doi:10.1093/jac/dkr394
32. Kunova A, Trupl J, Demitrovicova A et al (1997) Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis. Microb Drug Resist 3:283–287
33. Montagna MT, Lovero G, Borghi E et al (2014) Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur Rev Med Pharmacol Sci 18:661–674
34. Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M (2014) Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med 40:1241–1255. doi:10.1007/s00134-014-3404-7
35. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737. doi:10.1097/01.ccm.0000202208.37364.7d
36. Tissot F, Lamoth F, Hauser PM et al (2013) beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 188:1100–1109. doi:10.1164/rccm.201211-2069OC
37. Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med 40:1303–1312. doi:10.1007/s00134-014-3408-3
38. Shemer R, Weissman Z, Hashman N, Kornitzer D (2001) A highly polymorphic degenerate microsatellite for molecular strain typing of Candidakrusei. Microbiology 147:2021–2028
39. Grenouillet F, Millon L, Bart JM, Roussel S, Biot I, Didier E, Ong AS, Piarroux R (2007) Multiple-locus variable-number tandem-repeat analysis for rapid typing of Candidaglabrata. J Clin Microbiol 45:3781–3784. doi:10.1128/jcm.01603-07